Live Price
Live Volume
Chart Volume 0
Volume 0
5 secAligos Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $5.63 |
|---|---|
| Close | $5.63 |
| Low | $5.63 |
| Low Change | 0.00 (0.00%) |
| High | $5.63 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 911 |
| Dollar Volume | $5.13K |
Regular Trading Hours Yesterday
-0.02(-0.35%)
| Open | $5.65 |
|---|---|
| Close | $5.63 |
| Low | $5.54 |
| Low Change | -0.11 (-1.95%) |
| High | $5.80 |
| High Change | +0.15 (+2.65%) |
| Range | $0.26 |
| Volume | 31.253K |
| Dollar Volume | $175.95K |
Premarket Yesterday
+0.00(+0.00%)
| Open | $5.51 |
|---|---|
| Close | $5.51 |
| Low | $5.51 |
| Low Change | 0.00 (0.00%) |
| High | $5.51 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 500 |
| Dollar Volume | $2.76K |
Aligos Therapeutics News
1 month agoinvesting.comWhy is Aligos Therapeutics stock rallying 7% today?
- 3 months agoinvesting.com
Why is Aligos Therapeutics stock surging today?
- 3 months agoinvesting.com
Aligos Therapeutics stock jumps on $25M China licensing deal
- 6 months agoinvesting.com
Aligos Therapeutics stock surges on China licensing deal
- 8 months agoinvesting.com
Aligos Therapeutics stock rises on Phase 2 HBV study progress
Aligos Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Aligos Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $5.52 |
|---|---|
| 10 Day Moving Average (SMA10) | $5.47 |
| 20 Day Moving Average (SMA20) | $5.51 |
| 50 Day Moving Average (SMA50) | $5.74 |
| 100 Day Moving Average (SMA100) | $5.71 |
| 200 Day Moving Average (SMA200) | $6.77 |
Aligos Therapeutics Statistics
| Average Volume (30 Days) | 56.51K |
|---|---|
| P/E Ratio (Current) | -.46 |
| EPS (Current) | -$12.16 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$94.52M |
| Cash Ratio | 1.07 |
| Current Ratio | 2.19 |
| Quick Ratio | 2.19 |
| Debt to Equity | 0.00 |
| Enterprise Value | $4.78M |
| EV to EBITDA | -0.06 |
| EV to Sales | 0.15 |
| Price to Book | 1.10 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 1.11 |
| Return on Assets | -1.15% |
| Return on Equity | -2.38% |
Aligos Therapeutics Stock Splits
There has been 1 stock split for Aligos Therapeutics (ALGS). The reverse stock split occured on August 19, 2024 and reduced the outstanding shares at a ratio of 25:1.
| Date | Type | Ratio |
|---|---|---|
| Aug 19, 2024 | Reverse | 25:1 |
Aligos Therapeutics Dividends
There have been no dividends for Aligos Therapeutics (ALGS).